Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Richard Cowell Insider Profile
4 Followers
Richard Cowell, Director at Microvision, holds 34.44K shares in Microvision (Ticker: MVIS), holds 10.00K shares in ImmunoCellular Therapeutics (Ticker: IMUC).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-51.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Richard Cowell holds in companies
Most Profitable Insider Trade
The most profitable trade made by Richard Cowell
Richard Cowell's Trading History
Microvision
Jun 02, 2016
Director
Uninformative Buy
―
$79.20K
ImmunoCellular Therapeutics
Nov 27, 2013
Director
Uninformative Sell
289.10K
$2.54K
List of latest transactions for each holding click on a transaction to see Richard Cowell's performance on stock
You May Also Like
Richard Cowell insider profile FAQ
What is the percentage of profitable transactions made by Richard Cowell?
The percentage of profitable transactions made by Richard Cowell is 0%.
What is the average return per transaction made by Richard Cowell?
The average return per transaction made by Richard Cowell is -51.90%.
What stocks does Richard Cowell hold?
Richard Cowell holds: MVIS, IMUC stocks.
What was Richard Cowell’s latest transaction?
Richard Cowell latest transaction was an Uninformative Buy of ―.
What was Richard Cowell's most profitable transaction?
Richard Cowell’s most profitable transaction was an Informative Buy of MVIS stock on December 8, 2009. The return on the trade was -41.40%.
What is Richard Cowell's role in Microvision?
Richard Cowell's role in Microvision is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.